Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Biotech
Lilly M&A streak rolls on with purchase of DNA delivery biotech
Engage is developing novel non-viral DNA delivery systems that aim to overcome traditional limitations associated with the modality.
Eric Sagonowsky
May 20, 2026 10:48am
Lilly pens $2.2B gene editing pact with Bezos-backed Profluent
Apr 28, 2026 8:40am
Endoscopic procedure can help slow weight rebound from GLP-1s
Apr 27, 2026 8:48am
Lilly pens $2.3B deal for next-gen JAK inhibitor biotech Ajax
Apr 27, 2026 8:25am
After Lilly-Kelonia deal, are any in vivo biotechs left to buy?
Apr 24, 2026 9:30am
Lilly reneges on remainder of Rigel RIPK1 deal
Apr 22, 2026 3:00pm
